首页> 外文期刊>The Journal of Urology >Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer.
【24h】

Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer.

机译:直肠癌的术前解剖定位中直肠内磁共振成像,引导性前列腺活检和直肠指检的比较。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: We compared the accuracy of endorectal magnetic resonance imaging (erMRI), transrectal ultrasound (TRUS) guided biopsy and digital rectal examination (DRE) for detecting the location of cancer in the prostate gland and seminal vesicles. MATERIALS AND METHODS: This is a retrospective study of 106 consecutive patients with prostate cancer who were referred for erMRI before radical prostatectomy. Step-section pathological data and erMRI were available in 90 patients, DRE data were available on 86 and individually labeled sextant core biopsies were available in 45. T1 and T2-weighted erMRI was interpreted by a single reader, who scored the likelihood of tumor on a 5-point scale in each seminal vesicle and in 12 locations in the prostate gland. MR spectroscopy data were not used for erMRI interpretation. One pathologist reviewed whole mount serial sections of radical prostatectomy specimens. The area under ROC curves was used to evaluate accuracy. RESULTS: The area under ROC curves for tumor localization was higher for erMRI than for DRE at the prostatic apex (0.72 vs 0.66), mid gland (0.80 vs 0.69) and base (0.83 vs 0.69). It was likewise higher for erMRI than for TRUS biopsy in the mid gland (0.75 vs 0.68) and base (0.81 vs 0.61) but not in the apex (0.67 vs 0.70). On mixed model analysis erMRI significantly increased the accuracy of prostate cancer localization by DRE or TRUS biopsy (each p <0.0001). CONCLUSIONS: For prostate cancer localization erMRI contributes significant incremental value to DRE or TRUS biopsy findings (each p <0.0001).
机译:目的:我们比较了直肠内磁共振成像(erMRI),经直肠超声(TRUS)引导的活检和数字直肠检查(DRE)在前列腺和精囊中检测癌症位置的准确性。材料与方法:这是一项对106例前列腺癌患者的回顾性研究,这些患者在前列腺癌根治术前接受erMRI检查。 90例患者可获得阶梯状病理数据和erMRI,86例具有DRE数据,45例具有单独标记的六分体核心活检。单个阅读器解释了T1和T2加权erMRI,他们对肿瘤的可能性进行了评分。每个精囊和前列腺中12个位置的5点标度。 MR光谱数据未用于erMRI解释。一名病理学家回顾了前列腺癌根治术标本的整个系列连续切片。 ROC曲线下的面积用于评估准确性。结果:在前列腺顶点(0.72 vs 0.66),中腺(0.80 vs 0.69)和基部(0.83 vs 0.69),erMRI的ROC曲线下的肿瘤定位面积比DRE高。在中部腺体(0.75 vs 0.68)和基底(0.81 vs 0.61)中,erMRI的TRU活检率也高于TRUS活检,但在根尖(0.67 vs 0.70)则没有。在混合模型分析中,erMRI通过DRE或TRUS活检显着提高了前列腺癌定位的准确性(每个p <0.0001)。结论:对于前列腺癌,erMRI有助于DRE或TRUS活检结果的显着增加(每个p <0.0001)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号